Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Recursion Pharmaceuticals, Inc. (RXRX)  
$8.59 0.20 (2.28%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 208,280,000
Market Cap: 1.79(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $5.09 - $15.86
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, in vivo validation capabilities and a cross-functional team to discover medicines. Co.'s potential medicines include: REC-994 for the treatment of cerebral cavernous malformation; REC-2282 for the treatment of neurofibromatosis type 2; REC-4881 for the treatment of familial adenomatous polyposis; REC-3599 for the treatment of GM2 gangliosidosis; REC-3964 for the treatment of C. difficile colitis; REC-64917 for neural or systemic inflammation; and multiple simultaneous programs in fibrosis developing with Bayer AG.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,693,990
Total Buy Value $0 $0 $0 $12,897,789
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 27
Total Shares Sold 617,946 1,157,429 2,181,946 3,000,646
Total Sell Value $5,972,232 $10,903,828 $21,444,464 $28,622,080
Total People Sold 4 7 8 8
Total Sell Transactions 25 50 97 148
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 618
  Page 3 of 25  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mauro David J Chief Medical Officer   •       –      –    2024-02-09 4 A $0.00 $0 D/D 55,808 246,521     -
   Larson Tina Marriott President and COO   •       –      –    2024-02-09 4 D $10.09 $28,252 D/D (2,800) 645,361     -
   Larson Tina Marriott President and COO   •       –      –    2024-02-09 4 A $0.00 $0 D/D 233,613 648,161     -
   Secora Michael Chief Financial Officer   •       –      –    2024-02-09 4 D $10.09 $25,346 D/D (2,512) 1,161,351     -
   Secora Michael Chief Financial Officer   •       –      –    2024-02-09 4 A $0.00 $0 D/D 182,849 1,163,863     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-02-07 4 AS $9.22 $444,981 D/D (48,272) 774,703 -3%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-02-07 4 OE $2.48 $77,500 D/D 31,250 822,975     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-02-07 4 GD $0.00 $0 D/D 10,000 791,725     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-02-07 4 A $0.00 $0 D/D 10,000 801,725     -
   Borgeson Blake Director   –       •      –    2024-02-06 4 AS $9.30 $106,489 D/D (11,447) 7,312,917 -7%     
   Larson Tina Marriott President and COO   •       –      –    2024-01-25 4 AS $10.35 $82,762 D/D (8,000) 414,548 -14%     
   Larson Tina Marriott President and COO   •       –      –    2024-01-25 4 OE $1.06 $8,480 D/D 8,000 422,584     -
   Borgeson Blake Director   –       •      –    2024-01-23 4 AS $10.58 $212,083 D/D (20,054) 7,324,364 -17%     
   Secora Michael Chief Financial Officer   •       –      –    2024-01-17 4 AS $10.25 $256,348 D/D (25,000) 981,014 -14%     
   Secora Michael Chief Financial Officer   •       –      –    2024-01-17 4 OE $2.22 $83,250 D/D 37,500 1,006,014     -
   Secora Michael Chief Financial Officer   •       –      –    2024-01-16 4 AS $10.45 $261,160 D/D (25,000) 968,514 -18%     
   Secora Michael Chief Financial Officer   •       –      –    2024-01-16 4 OE $2.22 $83,250 D/D 37,500 993,514     -
   Virani Shafique Chief Business Officer   •       –      –    2024-01-16 4 AS $10.93 $196,740 D/D (18,000) 136,748 -18%     
   Virani Shafique Chief Business Officer   •       –      –    2024-01-16 4 OE $2.22 $39,960 D/D 18,000 154,748     -
   Li Dean Y Director   –       •      –    2024-01-09 4 AS $13.65 $396,214 I/I (29,000) 421,000 -34%     
   Borgeson Blake Director   –       •      –    2024-01-09 4 AS $13.21 $273,202 D/D (20,054) 7,344,418 -34%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-01-03 4 AS $9.49 $237,763 I/I (25,000) 0 -9%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-01-03 4 A $0.00 $0 I/I 25,000 1,000     -
   Gibson Christopher Chief Executive Officer   •       •      –    2024-01-03 4 AS $9.49 $292,804 D/D (30,853) 791,725 -9%     
   Gibson Christopher Chief Executive Officer   •       •      –    2024-01-03 4 OE $2.48 $77,500 D/D 31,250 822,578     -
  618 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 25
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us